What is Enovis's R&D?

Enovis (ENOV) reported R&D of $31.53M in Q1 2026.

How has Enovis's R&D changed year-over-year?

Enovis's R&D increased by 10.5% year-over-year, from $28.53M to $31.53M.

What is the long-term trend for Enovis's R&D?

Over 4 years (2021 to 2025), Enovis's R&D has grown at a 25.1% compound annual growth rate (CAGR), from $49.09M to $120.33M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Enovis ENOV R&D

R&D at other companies

StrykerSYK

$413M+2.0%

Zimmer Biomet HoldingsZBH

$103.4M-6.5%

VericelVCEL

$8.1M+11.6%

CONMEDCNMD

$16.33M+26.2%

Avanos MedicalAVNS

$5.2M-3.7%

Hinge Health, Inc.HNGE

$30.34M+29.1%

Segments

By segment

See full

Reconstructive$23.79M+23.3%

Prevention & Recovery$7.75M—

Other financials

Income statement

See full

Revenue$589.2M+5.4%

Gross profit$365.5M+10.0%

Operating income$6.5M+114%

Net income-$8.8M+84.3%

EPS (diluted)-$0.15+84.7%

Balance sheet

See full

Cash & equivalents$33.1M-13.9%

Total debt$1.4B-3.1%

Total equity$1.5B-43.6%

Total assets$3.8B-21.4%

Cash flow

See full

Operating cash flow$24.0M+1,601%

CapEx$52.8M+22.1%

Free cash flow-$28.9M+35.7%

Valuation

See full

Market cap$1.23B-28.4%

Enterprise value$2.55B-17.1%

P/S0.5×-0.3×

Profitability

See full

Gross margin60.5%+4.0pp

Operating margin-47%+18.6pp

Net margin-49.9%+24.1pp

FCF margin-3.1%-1.1pp

Returns & leverage

See full

Return on equity-55.5%-1,722pp

Debt / equity0.9×+0.4×

Current ratio2×-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Enovis's R&D?: Enovis (ENOV) reported R&D of $31.53M in Q1 2026.
How has Enovis's R&D changed year-over-year?: Enovis's R&D increased by 10.5% year-over-year, from $28.53M to $31.53M.
What is the long-term trend for Enovis's R&D?: Over 4 years (2021 to 2025), Enovis's R&D has grown at a 25.1% compound annual growth rate (CAGR), from $49.09M to $120.33M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.